<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="21700">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01906112</url>
  </required_header>
  <id_info>
    <org_study_id>17_2013RC_IN305</org_study_id>
    <nct_id>NCT01906112</nct_id>
  </id_info>
  <brief_title>Role of Surgery for the Primary in Patients With Breast Cancer Stage IV.</brief_title>
  <official_title>Role of Surgery for the Primary in Patients With Breast Cancer Stage IV - A Prospective Randomized Multicenter Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Cancer Institute, Thailand</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Vichaiyut Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>National Cancer Institute, Thailand</source>
  <oversight_info>
    <authority>Thailand: Ministry of Public Health</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine benefits of surgery for the primary in patients
      with breast cancer stage IV in randomized controlled study.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2013</start_date>
  <completion_date type="Anticipated">August 2019</completion_date>
  <primary_completion_date type="Anticipated">August 2014</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Overall survival</measure>
    <time_frame>Five years</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quality of life &amp; Uncontrolled chest wall disease</measure>
    <time_frame>Five years</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">476</enrollment>
  <condition>Carcinoma Breast Stage IV</condition>
  <arm_group>
    <arm_group_label>Controlled</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>No surgery for primary breast tumor.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Study</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Surgery for primary breast tumor.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Surgery for primary breast tumor.</intervention_name>
    <description>Complete resection of primary breast tumor(Lumpectomy or mastectomy)</description>
    <arm_group_label>Study</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy breast cancer stage IV patients with resectable primary breast tumor.

          -  Resectable breast cancer stage IV patients who well response of visceral metastasis
             to systemic therapy and fit for surgery.

        Exclusion Criteria:

          -  Breast cancer stage IV patients with local complication of primary breast tumor that
             require surgery for palliation such as uncontrolled bleeding,large and non-healing
             ulcer or intractable pain.

          -  Breast cancer stage IV patients with unresectable primary breast tumor or extensive
             chest wall disease.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>AKANIST PIYAPANT, MD.,FRCST.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Vichaiyut Hospital &amp; Medical Center, Bangkok, Thailand</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>AKANIST PIYAPANT, MD.FRCST.</last_name>
    <phone>+6622657777</phone>
    <email>AKANISTP.VCYH@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Division Head &amp; Neck and Breast, Department of Surgery. Faculty of Medicine Siriraj Hospital</name>
      <address>
        <city>Bangkok Noi</city>
        <state>Bangkok</state>
        <zip>10700</zip>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Visanu Lohsiriwat, MD,FRCST,FICS.</last_name>
    </contact>
    <investigator>
      <last_name>Visanu Lohsiriwat, MD,FRCST,FICS.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Department of Surgery, Faculty of Medicine Vajira Hospital.</name>
      <address>
        <city>Dusit</city>
        <state>Bangkok</state>
        <zip>10300</zip>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Satit Srimontayamas, MD.,FRCST.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pakorn Bunsakulsopit, MD.,FRCST.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Vichaiyut Hospital &amp; Medical Center</name>
      <address>
        <city>PhyaThai</city>
        <state>Bangkok</state>
        <zip>10400</zip>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>AKANIST PIYAPANT, MD.,FRCST.</last_name>
      <phone>+6622657777</phone>
      <email>AKANISTP.VCHY@gmail.com</email>
    </contact>
    <investigator>
      <last_name>AKANIST PIYAPANT, MD.,FRCST.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Phramongkutklao Hospital</name>
      <address>
        <city>Ratchathewi</city>
        <state>Bangkok</state>
        <zip>10400</zip>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Sukchai Stthaporn, MD,PhD,FRCST.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>National Cancer Institute</name>
      <address>
        <city>Ratchathewi</city>
        <state>Bangkok</state>
        <zip>10400</zip>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Terminated</status>
  </location>
  <location>
    <facility>
      <name>Chonburi Cancer Hospital</name>
      <address>
        <city>Muang Chonburi</city>
        <state>Chonburi</state>
        <zip>20000</zip>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Khon Kaen University</name>
      <address>
        <city>Muang</city>
        <state>Khon Kaen</state>
        <zip>40002</zip>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ongart Somintara, MD.,FRCST.</last_name>
    </contact>
    <investigator>
      <last_name>Ongart Somintara, MD.,FRCST.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Suratthani Cancer Hospital</name>
      <address>
        <city>Muang Suratthani</city>
        <state>Suratthani</state>
        <zip>84100</zip>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Udon Thani Cancer Hospital</name>
      <address>
        <city>Muang Udon Thani</city>
        <state>Udon Thani</state>
        <zip>41330</zip>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <reference>
    <citation>Khan SA, Stewart AK, Morrow M. Does aggressive local therapy improve survival in metastatic breast cancer? Surgery. 2002 Oct;132(4):620-6; discussion 626-7.</citation>
    <PMID>12407345</PMID>
  </reference>
  <reference>
    <citation>Gnerlich J, Jeffe DB, Deshpande AD, Beers C, Zander C, Margenthaler JA. Surgical removal of the primary tumor increases overall survival in patients with metastatic breast cancer: analysis of the 1988-2003 SEER data. Ann Surg Oncol. 2007 Aug;14(8):2187-94. Epub 2007 May 24.</citation>
    <PMID>17522944</PMID>
  </reference>
  <reference>
    <citation>Rapiti E, Verkooijen HM, Vlastos G, Fioretta G, Neyroud-Caspar I, Sappino AP, Chappuis PO, Bouchardy C. Complete excision of primary breast tumor improves survival of patients with metastatic breast cancer at diagnosis. J Clin Oncol. 2006 Jun 20;24(18):2743-9. Epub 2006 May 15.</citation>
    <PMID>16702580</PMID>
  </reference>
  <reference>
    <citation>Shien T, Kinoshita T, Shimizu C, Hojo T, Taira N, Doihara H, Akashi-Tanaka S. Primary tumor resection improves the survival of younger patients with metastatic breast cancer. Oncol Rep. 2009 Mar;21(3):827-32.</citation>
    <PMID>19212646</PMID>
  </reference>
  <reference>
    <citation>Neuman HB, Morrogh M, Gonen M, Van Zee KJ, Morrow M, King TA. Stage IV breast cancer in the era of targeted therapy: does surgery of the primary tumor matter? Cancer. 2010 Mar 1;116(5):1226-33. doi: 10.1002/cncr.24873.</citation>
    <PMID>20101736</PMID>
  </reference>
  <verification_date>March 2014</verification_date>
  <lastchanged_date>March 15, 2014</lastchanged_date>
  <firstreceived_date>July 15, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>National Cancer Institute, Thailand</investigator_affiliation>
    <investigator_full_name>AKANIST  PIYAPANT, MD.,FRCST.</investigator_full_name>
    <investigator_title>Surgical Oncologist.</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Breast Neoplasms</mesh_term>
    <mesh_term>Carcinoma</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
